An Overview of Randomised Studies Comparing 5-HT 3 Receptor Antagonists to Conventional Anti-emetics in the Prophylaxis of Acute Chemotherapy-induced Vomiting

By Jantunen I.T.   Kataja V.V.   Muhonen T.T.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 67-74

Elsevier

Access to resources Recommend Favorite

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

By Jordan K.   Hinke A.   Grothey A.   Voigt W.   Arnold D.   Wolf H.-H.   Schmoll H.-J.  

Supportive Care in Cancer, Vol. 15, Iss. 9, 2007-09 ,pp. : 1023-1033

Springer Publishing Company

Access to resources Recommend Favorite

The cost of chemotherapy-induced nausea and vomiting in Italy

By Ballatori Enzo   Roila Fausto   Ruggeri Benedetta   Porrozzi Stella   Iannopollo Mauro   Soru Giancarla   Cruciani Giorgio   Daniele Bruno   Locatelli Maria   Pellissier James   Deuson Robert  

Supportive Care in Cancer, Vol. 15, Iss. 1, 2007-01 ,pp. : 31-38

Springer Publishing Company

Access to resources Recommend Favorite

New treatment options for chemotherapy-induced nausea and vomiting

By Hesketh Paul  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 550-554

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review

By Hocking Christopher   Kichenadasse Ganessan  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 1143-1151

Springer Publishing Company

Access to resources Recommend Favorite